Immuneering Corporation (IMRX)
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates.
Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.
NeoGenomics, Inc. (NEO)
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments.